Details for Patent: 6,670,351
✉ Email this page to a colleague
Summary for Patent: 6,670,351
Title: | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
Abstract: | A method for attenuating the HIV-associated myopathy and muscle wasting associated with infection by human immunodeficiency virus-Type 1. Administration of oxandrolone in a daily dosage of about 2.5 to about 20 milligrams is described. |
Inventor(s): | Berger; Joseph R. (Miami, FL) |
Assignee: | Bio-Technology General Corporation (Iselin, NJ) |
Application Number: | 09/469,817 |
Patent Claim Types: see list of patent claims | Use; Delivery; Dosage form; |
Drugs Protected by US Patent 6,670,351
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,670,351
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 5445994 | ⤷ Try a Trial | |||
Israel | 107328 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 9408590 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |